N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial.
about
N-acetylcysteine in the treatment of psychiatric disorders: current status and future prospects.How Similar Are the Disorders Included Under the Umbrella of Obsessive-Compulsive Disorder and Related Disorders?-Reply.Wide range of age of onset and low referral rates to psychiatry in a large cohort of acne excoriée at a Swiss tertiary hospital.Obsessive-compulsive disorder: Insights from animal models.Glutamate-modulating drugs as a potential therapeutic strategy in obsessive-compulsive disorder.Comparison of Saffron and Fluvoxamine in the Treatment of Mild to Moderate Obsessive-Compulsive Disorder: A Double Blind Randomized Clinical Trial.Mavoglurant Augmentation in OCD Patients Resistant to Selective Serotonin Reuptake Inhibitors: A Proof-of-Concept, Randomized, Placebo-Controlled, Phase 2 Study.L-carnosine as an adjuvant to fluvoxamine in treatment of obsessive compulsive disorder: A randomized double-blind study.Mapping Compulsivity in the DSM-5 Obsessive Compulsive and Related Disorders: Cognitive Domains, Neural Circuitry, and Treatment.Lost in translation? A critical look at the role that animal models of obsessive compulsive disorder play in current drug discovery strategies.Individualized Immunological Data for Precise Classification of OCD Patients
P2860
Q34543171-179F745D-97E0-4940-B37A-2F309C0B1546Q37665130-6EA19A65-1C88-406A-A9A6-E00423A9FDF7Q38636662-96C3530C-4D83-441B-8116-56A5F446ECFCQ38832138-E38F8334-79EF-473D-BFC4-E2799AA082A8Q39189451-781E4B29-A6B6-4B18-8018-33FE52ED59CAQ43465133-2624FC0B-1429-47EA-8945-4BFDA7E72BA1Q46490665-F6AD7C96-1E8A-4BA3-AD0A-F7E33B85A11AQ47728541-B927660C-8B31-45AB-8801-57975087EC37Q48016660-A9CC3D97-E10A-43C7-AEAE-1348A4A9FE36Q49591645-56602BDC-3DDA-4F77-97EC-7BDE17D092B3Q56888722-A5DA8B21-CC75-4746-8EA0-5F07D01B6757
P2860
N-acetylcysteine augmentation therapy for moderate-to-severe obsessive-compulsive disorder: randomized, double-blind, placebo-controlled trial.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
N-acetylcysteine augmentation ...... ind, placebo-controlled trial.
@en
N-acetylcysteine augmentation ...... ind, placebo-controlled trial.
@nl
type
label
N-acetylcysteine augmentation ...... ind, placebo-controlled trial.
@en
N-acetylcysteine augmentation ...... ind, placebo-controlled trial.
@nl
prefLabel
N-acetylcysteine augmentation ...... ind, placebo-controlled trial.
@en
N-acetylcysteine augmentation ...... ind, placebo-controlled trial.
@nl
P2093
P2860
P356
P1476
N-acetylcysteine augmentation ...... ind, placebo-controlled trial.
@en
P2093
A Ahmadipour
A Akamaloo
S Akhondzadeh
S Emamzadehfard
P2860
P304
P356
10.1111/JCPT.12370
P577
2016-03-02T00:00:00Z